Could The US FDA Set Clinical Trial Diversity Minimums?

 
• By Derrick Gingery
Cancer clinical trial diversity panel discussion
FDA, industry and patient advocates discussed clinical trial diversity issues during a 4 May Cancer Moonshot community conversation. • Source: screenshot

More from Clinical Trials

More from R&D